tiprankstipranks
Advertisement
Advertisement

Dr. Martens Confirms Total Voting Rights at Just Under 967.5 Million Shares

Story Highlights
  • Dr. Martens confirms it has 967,472,963 ordinary shares in issue, all with voting rights.
  • The updated share count gives investors a clear denominator for U.K. disclosure and transparency rules.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Dr. Martens Confirms Total Voting Rights at Just Under 967.5 Million Shares

Claim 55% Off TipRanks

Dr. Martens Plc ( (GB:DOCS) ) has shared an announcement.

Dr. Martens plc has confirmed that its issued ordinary share capital stands at 967,472,963 shares, each carrying one voting right, with no shares held in treasury. This figure establishes the definitive total of voting rights for investors to use when assessing whether they must disclose new or changed holdings under U.K. transparency rules, providing clarity for shareholders and the wider market.

The disclosure supports orderly governance and regulatory compliance by giving an updated denominator for ownership calculations across the shareholder base. By reinforcing transparency around its capital structure, Dr. Martens offers investors a clearer view of its equity profile at a time when accurate voting-rights data is essential for institutional reporting and stewardship activities.

The most recent analyst rating on (GB:DOCS) stock is a Hold with a £62.00 price target. To see the full list of analyst forecasts on Dr. Martens Plc stock, see the GB:DOCS Stock Forecast page.

Spark’s Take on DOCS Stock

According to Spark, TipRanks’ AI Analyst, DOCS is a Neutral.

Dr. Martens Plc’s overall stock score reflects a mix of financial challenges and strategic progress. The most significant factor is the company’s financial performance, which is hindered by declining revenue and profitability. Technical analysis indicates bearish momentum, while valuation suggests the stock is overvalued. Positive corporate events and earnings call insights provide some optimism, but challenges remain.

To see Spark’s full report on DOCS stock, click here.

More about Dr. Martens Plc

Dr. Martens plc is an iconic British footwear company best known for its 1460 boot and other durable, air-cushioned “Docs” and “DM’s” styles that have evolved from workwear into global fashion staples. The brand sells through direct-to-consumer and wholesale channels in more than 60 countries, maintains its heritage ‘Made in England’ line alongside Asian production, and is listed on the London Stock Exchange as a FTSE 250 constituent.

Average Trading Volume: 1,589,359

Technical Sentiment Signal: Strong Sell

Current Market Cap: £603.2M

For a thorough assessment of DOCS stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1